| Literature DB >> 34885883 |
Fahd Kandsi1, Raffaele Conte2, Mohamed Marghich1, Fatima Zahra Lafdil1, Mohamed F Alajmi3, Mohamed Bouhrim1, Hamza Mechchate4, Christophe Hano5, Mohammed Aziz1, Nadia Gseyra1.
Abstract
Dysphania ambrosioides (L.) Mosyakin and Clemants is an annual or ephemeral perennial herb used traditionally in the Mediterranean region in folk medicine to treat various illnesses, including those related to the digestive system. This study aims to assess the antispasmodic, myorelaxant, and antioxidant effects of D. ambrosioides flower hydroethanolic extract and its chloroform and ethyl acetate fractions in a comparative study to evaluate the result of the extraction type on the potential activity of the extract. Both rat and rabbit jejunum were used to evaluate the antispasmodic and myorelaxant effect, while the antioxidant effect was evaluated using DPPH, a ferric reducing power assay, and a beta-carotene bleaching test. LC/MS-MS analysis was carried out to reveal the composition of the different types of extract. Following the results, the hydroethanolic extract showed a significant myorelaxant effect (IC50 = 0.39 ± 0.01 mg/mL). Moreover, it was shown that the hydroethanolic extract demonstrated the best antispasmodic activity (IC50 = 0.51 ± 0.05 mg/mL), followed by the ethyl acetate (IC50 = 4.05 ± 0.32 mg/mL) and chloroform (IC50 = 4.34 ± 0.45 mg/mL) fractions. The antioxidant tests showed that the hydroethanolic extract demonstrated high antioxidant activity, followed by the ethyl acetate and chloroform fractions. The LC/MS-MS analysis indicates that the plant extract was rich in flavonoids, to which the extract activity has been attributed. This study supports the traditional use of this plant to treat digestive problems, especially those with spasms.Entities:
Keywords: Chenopodium ambrosioides; LC/MS-MS; antispasmodic; carbachol; extraction; fractionation; rabbit jejunum; rat jejunum; verapamil
Mesh:
Substances:
Year: 2021 PMID: 34885883 PMCID: PMC8659140 DOI: 10.3390/molecules26237300
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The yield of the hydroethanolic extract and the chloroform and ethyl acetate fractions. HEE—hydroethanolic extract; CE—chloroform extract; EAE—ethyl acetate extract.
Figure 2Most abundant molecules in the D. ambrosioides extract.
Phytochemical composition of the extract and fractions revealed by LC-MS/MS.
| Molecule | Hydroethanolic Extract | Ethyl Acetate Fraction | Chloroform Fraction |
|---|---|---|---|
| Catechin gallate (epicatechin gallate) | − | + | + |
| Amentoflavone | − | + | + |
| Arbutin | − | + | − |
| Caffeic acid | + | − | − |
| Ferulic acid | − | + | − |
| Gallocatechin/Epigallocatechin gallate | − | + | + |
| Hesperetin | ++ | +++ | + |
| Isorhamnetin-3- | − | + | + |
| Isorhamnetin-7- | + | + | + |
| Kaempferol | ++ | +++ | − |
| Kaempferol-3- | + | − | + |
| Kaempferol-3- | − | + | + |
| Kaempferol-3- | + | + | + |
| Kaempferol-3- | + | + | +++ |
| Luteolin | ++ | ++ | − |
| Luteolin 7- | + | + | + |
| Myricetin | − | + | + |
| Naringin | + | − | − |
| Oleochantal | − | + | − |
| + | − | − | |
| + | ++ | − | |
| Procyanidin | + | + | − |
| Quercetin | ++ | +++ | ++ |
| Quercetin-3- | − | + | + |
| Quercetin-3-O-glucuronoside | − | + | + |
| Quercetin-3- | + | − | + |
| Rosmarinic acid | + | + | ++ |
| Rutin | + | − | − |
| Syringic acid | +++ | +++ | +++ |
| + | + | − | |
| Trimethoxyflavone | − | + | ++ |
| Ursolic acid | − | + | + |
+++: High abundance, ++: abundant, +: low abundance, −: not detectable in the extract.
Antioxidant activity of D. ambrosioides extract and fractions.
| Samples | IC50 (µg/mL) | ||
|---|---|---|---|
| DPPH | β-Carotene | FRAP | |
| Hydroethanolic extract | 166.47 ± 1.74 NS | 57.04 ± 0.06 ≠ | 231.5 ± 0.25 NS |
| Chloroform fraction | 1043 ± 1.04 *** | 66.01 ± 1.00 ≠≠ | 1017.8 ± 0.57 ** |
| Ethyl acetate fraction | 156.8 ± 0.96 NS | 60.1 ± 1.06 ≠ | 511.8 ± 0.30 NS |
| Ascorbic acid | 137.7 ± 0.05 | - | 33.7 ± 0.01 |
| BHA | 32.02 ± 2.6 | ||
BHA—butylated hydroxyanisole; DPPH—2,2-diphényl-1-picrylhydrazyl; FRAP—ferric reducing power assay. NS: not significant; ** p ≤ 0.01 and *** p ≤ 0.001 in comparison with the ascorbic acid; p ≤ 0.05 and p ≤ 0.01 in comparison with the BHA.
Figure 3Effect of the DaHEE on rat jejunum precontracted by carbachol 10−6 M. NS: not significant; *** p ≤ 0.001 in comparison with the control. The values are the means ± SEM (n = 5). DaHEE—D. ambrosioides hydroethanolic extract; CCh—carbachol.
Figure 4Effect of the DaEAE on rat jejunum precontracted by carbachol 10−6 M. ns: not significant; ** p ≤ 0.01 and *** p ≤ 0.001 in comparison with the control. The values are the means ± SEM (n = 5). DaEAE—D. ambrosioides ethyl acetate extract; CCh—carbachol.
Figure 5Effect of the DaCE on rat jejunum precontracted by carbachol 10−6 M. ns: not significant; * p ≤ 0.05 and *** p ≤ 0.001 compared to the control. The values are the means ± SEM (n = 4). DaCE—D. ambrosioides chloroform extract; CCh—carbachol.
Figure 6Myorelaxant effect of DaHEE flowers(A) and verapamil (B) and the on spontaneous contractions of the rabbit jejunum. NS: not significant; ** p ≤ 0.01 and *** p ≤ 0.001 compared to the control. The values are the means ± SEM (n = 6). DaHEE—D. ambrosoidese hydroethanolic extract.